Effectiveness of cervical cancer screening over cervical cancer mortality among Japanese women

Japanese Journal of Clinical Oncology

Volumn 36, Issue 8, 2006, Pages 511-518

  Aklimunnessa, Khandoker ^a   Mori, Mitsuru ^a   Khan, M M H ^a   Sakauchi, Fumio ^a   Kubo, Tatsuhiko ^b   Fujino, Yoshihisa ^c   Suzuki, Sadao ^d   Tokudome, Shinkan ^d   Tamakoshi, Akiko ^e  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c Fukuoka Institute of Occupational Health   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer mortality; Cohort study; Japan; Pap smear test

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DELIVERY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; PROPORTIONAL HAZARDS MODEL; RISK REDUCTION; SELF REPORT; UTERINE CERVIX CANCER;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; JAPAN; MASS SCREENING; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33750092720     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl060     Document Type: Article

References (58)

1. Parkin M, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J Natl Cancer Inst 2002;94:1469-83.
3. Quinn M, Babb P, Jones J, Allen J. Effect of screening on incidence of and mortality from cancer of cervix in England: Evaluation based on routinely collected statistics. Br Med J 1999;318:904-8.
4. Shapiro S, Carrara H, Allan BR, Hoffman M, Rosenberg L, Kelly JP, et al. Hypothesis: The act of taking a Papanicolaou smear reduces the prevalence of human papillomavirus infection: A potential impact on the risk of cervical cancer. Cancer Causes Control 2003;14:953-7.
5. Gustafsson L, Ponten J, Zack M, Adami H-O. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997;8:755-63.
6. Miller AB. Editorial: Failures of cervical cancer screening. Am J Public Health 1995;85:761-2.
7. Waxman AG. Guidelines for cervical cancer screening: History and scientific rationale. Clin Obstet Gynecol 2005;48:77-97.
8. Hoffman MS, Cavanagh D. Cervical cancer. In: Reintgen DS, Clark RA, editors. Cancer Screening. Missouri: Mosby-Year Book, Inc. 1996;41-54.
9. Hakama M, Chamberlain J, Day NE, Miller AB, Prorok PC. Evaluation of screening programmes for gynaecological cancer. Br J Cancer 1985;52: 669-73.
10. Boyle P. Screening. Eur Respir J 2003;21:3S-15s.
11. Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005;14:677-86.
12. Ronco G, Pilutti S, Patriarca S, Montanari G, Ghiringhello B, Volante R, et al. Impact of the introduction of organized screening for cervical cancer in Turin, Italy: Cancer incidence by screening history 1992-98. Br J Cancer 2005;93:376-8.
13. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: Epidemiology, prevention, and the role of human papillomavirus infection. Can Med Assoc J 2001;164:1017-25.
14. Makino H, Sato S, Yajima A, Komatsu S, Fukao A. Evaluation of the effectiveness of cervical cancer screening: A case-control study in Miyagi, Japan. Tohoku J Exp Med 1995;175:171-8.
15. Sigurdsson K. Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991. Int J Cancer 1993;5:563-70.
16. Herrero R, Brinton LA, Reeves WC, Brenes MM, de Britton RC, Gaitan E, et al. Screening for cervical cancer in Latin America: A case-control study. Int J Epidemiol 1992;21:1050-6.
17. Lynge E, Madsen M, Engholm G. Effect of organized screening on incidence and mortality of cervical cancer in Denmark. Int J Cancer 1989;49:2157-60.
18. Sobue T, Suzuki T, Hashimoto S, Yokoi N, Fujimoto I. A case-control study of the effectives of cervical cancer screening in Osaka, Japan. Jpn J Cancer Res 1988;79:1269-75.
19. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organized screening programmes. Lancet 1987;1:1247-9.
20. Sato S, Matsunaga G, Konno R, Yajima A. Mass screening for cancer of the uterine cervix in Miyagi prefecture, Japan. Acta Cytol 1998;42:299-304.
21. Matsunaga G, Tsuji I, Sato S, Fukao A, Hisamichi S, Yajima A. Cost-effectiveness analysis of mass screening for cervical cancer in Japan. J Epidemiol 1997;7:135-41.
22. Ioka A, Tsukuma H, Ajiki W, Oshima A. Influence of age on cervical cancer survival in Japan. Jpn J Clin Oncol 2005;35:464-9.
23. Comber H, Gavin A. Recent trends in cervical cancer mortality in Britain and Ireland: The case for population-based cervical cancer screening. Br J Cancer 2004;91:1902-4.
24. Ioka A, Tsukuma H, Ajiki W, Oshima A. Trends in uterine cancer incidence in Japan 1975-98. Jpn J Clin Oncol 2003;33:645-6.
25. Potischman N, Brinton LA. Nutrition and cervical neoplasia. Cancer Causes Control 1996;7:113-26.
26. Herrero R, Potischman N, Brinton LA, Reeves WC, Brenes MM, Tenorio F, et al. A case-control study of nutrient status and invasive cervical cancer: Dietary indicators. Am J Epidemiol 1991;134:1335-46.
27. Verreault R, Chu J, Mandelson M, Shy K. A case-control study of diet and invasive cervical cancer. Int J Cancer 1989;43:1050-4.
28. Brock KE, Berry G, Mock PA, MacLennan R, Truswell AS, Brinton LA. Nutrients in diet and plasma and risk of in situ cervical cancer. J Natl Cancer Inst 1988;80:580-5.
29. Turkistanli EC, Sogukpinar N, Saydarn Bk, Aydemir G. Cervical cancer prevention and early detection- the role of nurses and midwives. Asian Pac J Cancer Prev 2003;4:15-21.
30. Murthy NS, Mathew A. Risk factors for pre-cancerous lesions of the cervix. Eur J Cancer Prev 2000;9:5-14.
31. Hammouda D, Munoz N, Herrero R, Arslan A, Bouhadef A, Oublil M, et al. Cervical carcinoma in Algiers, Algeria: Human papillomavirus and lifestyle risk factors. Int J Cancer 2005;113:483-9.
32. Shields TS, Brinton LA, Burk RD, Wang SS, Weinstein SJ, Ziegler RG, et al. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev 2004;13:1574-82.
33. Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJF, et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: A case-control study. Int J Cancer 2003;107:127-33.
34. Bayo S, Bosch FX, de Sanjose S, Munoz N, Combita AL, Coursaget P, et al. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002;31:202-9.
35. Stuver S, Adami H-O. Cervical cancer. In: Adami H-O, Hunter D, Trichopoulos D, editors. Textbook of Cancer Epidemiology. New York: Oxford University Press 2002;340-58.
36. Zondervan KT, Carpenter LM, Painter R, Vessey MP. Oral contraceptives and cervical cancer-further findings from the Oxford Family Planning Association contraceptive study. Br J Cancer 1996;73:1291-7.
37. Ohno Y, Tamakoshi A and the JACC study group. Japan Collaborative Cohort Study of cancer risk sponsored by Monbusho (JACC Study). J Epidemiol 2001;11:144-50.
38. Sakauchi F, Mori M, Washio M, Watanabe Y, Ozasa K, Hayashi K, et al. Dietary habits and risk of urothelial cancer incidence in the JACC Study. J Epidemiol 2005;15(Suppl 2):S190-5.
39. Mizoue T, Yoshimura T, Tokui N, Hoshiyama Y, Yatsuya H, Sakata K, et al. Prospective study of screening for stomach cancer in Japan. Int J Epidemiol 2003;106:103-7.
40. Rothman KJ. Epidemiology: An Introduction. New York: Oxford University Press 2002;96-7.
41. Ikeda A, Iso H, Toyoshima H, Fujino Y, Mizoue T, Yoshimura T, et al. The relationship between interest for and participation in health screening and risk of mortality: The Japan Collaborative Cohort Study. Prev Med 2005;41:767-71.
42. Miller AB, Goel V. Screening. In: Detels R, McEwen J, Beaglehole R, Tanaka H, editors. Oxford Textbook of Public Health. New York: Oxford University Press 2004;1823-37.
43. Magnus K, Langmark F, Andersen A. Mass screening for cervical cancer screening in Ostfold county of Norway 1959-77. Int J Cancer 1987;39: 311-6.
44. Saslow D, Runowicz CD, Solomon D. American cancer society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-62.
45. Kitazawa R. Cancer screening services: Comparison between Japan and the United States. Special Scientific Report No. 00-13. Tokyo: National Science Foundation Tokyo Regional Office 2000.
46. Hirano Y, Ojima T. Analyses of factors influencing participation in the cervical cancer screening programme in the community in Japan. J Epidemiol 1997;7:125-33.
47. Abe Y, Ito K, Okamura C, Niikura H, Terada Y, Murakami T, et al. Cervical cytologic examination during physical checkup for pregnant women: Cervical cancer screening in women under the age of thirty. Tohoku J Exp Med 2004:204;221-8.
48. Koopmanschap MA, van Oortmarssen GJ, van Agt HMA, van Ballegooijen M, Habbema JDF, Lubbe KTH. Cervical-cancer screening: Attendance and cost-effectiveness. Int J Cancer 1990;45:410-5.
49. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin M. International trends in the incidence of cervical cancer: I. adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998;75:536-45.
50. Ito T, Ishizuka T, Suzuki K, Ikoma Y, Saito J, Onuma M, et al. Cervical cancer in young Japanese women. Arch Gynecol Obstet 2000;264:68-70.
51. Weiss NS, Rossing MA. Healthy screenee bias in epidemiologic studies of cancer incidence. Epidemiology 1996;7:19-22.
52. Friedman DR, Dubin N. Case-control evaluation of breast cancer screening efficacy. Am J Epidemiol 1991;133:974-84.
53. Raffle AE. Commentary: Case-control studies of screening should carry a health warning. Int J Epidemiol 2003;32:577-8.
54. Rossi PG, Esposito G, Brezzi S, Brachini A, Raggi P, Federici A. Estimation of Pap-test coverage in an area with an organized screening program: Challenges for survey method. BMC Health Serv Res 2006;6:36.
55. Bancej CM, Maxwell CJ, Snider J. Inconsistent self-reported mammography history: Findings from the National Population Health Survey longitudinal cohort. BMC Health Serv Res 2004;4:32.
56. Hancock L, Sanson-Fisher R, Kentish L. Cervical cancer screening in rural NSW: Health insurance commission data composed to self-report. Aus N Z J Public Health 1998;22(Suppl):307-12.
57. Munk C, Kjaer SK, Poll P, Bock JE. Cervical cancer screening: Knowledge of own screening status among women aged 20-29 years. Acta Obstet Gynecol Scand 1998;77:917-22.
58. Bowman JA, Sanson-Fisher R, Redman S. The accuracy of self-reportrd Pap smear utilization. Soc Sci Med 1997;44:969-76.